Cargando…

Alopecia Universalis in an Elderly Chinese Man Induced by Sacubitril/Alisartan, a Novel Angiotensin Receptor-Neprilysin Inhibitor

Drug-induced alopecia areata is a rare adverse event wherein medications such as antimicrobials, anticonvulsants, and biologics, trigger the premature transition of actively growing hairs into the telogen phase. Herein, a unique case of alopecia universalis observed during a clinical trial involving...

Descripción completa

Detalles Bibliográficos
Autores principales:	Teng, Yan, Fan, Yibin, Shang, Danying, Tao, Xiaohua, Sun, Dongsheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10447223/ https://www.ncbi.nlm.nih.gov/pubmed/37636274 http://dx.doi.org/10.2147/JIR.S427937

Ejemplares similares

Sacubitril/valsartan: A novel angiotensin receptor-neprilysin inhibitor
por: Dargad, Ramesh R., et al.
Publicado: (2018)

In silico study of inhibitory capacity of sacubitril/valsartan toward neprilysin and angiotensin receptor
por: Jovanović, Jelena Đorović, et al.
Publicado: (2022)

LCZ696 (sacubitril/valsartan), an angiotensin receptor neprilysin inhibitor (ARNI): clinical development in heart failure
por: Lefkowitz, Martin P
Publicado: (2015)

Angiotensin II Receptor–Neprilysin Inhibitor Sacubitril/Valsartan Improves Endothelial Dysfunction in Spontaneously Hypertensive Rats
por: Seki, Takunori, et al.
Publicado: (2017)

Effect of the angiotensin receptor–neprilysin inhibitor sacubitril/valsartan on the pharmacokinetics and pharmacodynamics of a single dose of furosemide
por: Ayalasomayajula, Surya, et al.
Publicado: (2018)

Structure of neprilysin in complex with the active metabolite of sacubitril
por: Schiering, Nikolaus, et al.
Publicado: (2016)

Bimatoprost in the Treatment of Eyelash Universalis Alopecia Areata
por: Vila, Teresa Ojeda, et al.
Publicado: (2010)

Alopecia universalis in a patient with Sheehan's syndrome
por: Bansal, Shivani, et al.
Publicado: (2016)

Transient Efficacy of Tofacitinib in Alopecia Areata Universalis
por: Anzengruber, Florian, et al.
Publicado: (2016)

Improvement of atopic dermatitis and alopecia universalis with dupilumab
por: Alotaibi, Lama, et al.
Publicado: (2021)

Effective treatment of alopecia universalis with oral upadacitinib
por: Youssef, Soundos, et al.
Publicado: (2022)

Dual Angiotensin Receptor-Neprilysin Inhibition With Sacubitril/Valsartan Attenuates Systolic Dysfunction in Experimental Doxorubicin-Induced Cardiotoxicity
por: Boutagy, Nabil E., et al.
Publicado: (2020)

Clinical Characteristics and Prognostic Factors in Early-Onset Alopecia Totalis and Alopecia Universalis
por: Cho, Hyun Hee, et al.
Publicado: (2012)

Diphenylcyclopropenone-Induced Vitiligo in a Patient with Alopecia Universalis
por: Riad, Hassan, et al.
Publicado: (2013)

Alopecia Universalis in Polyglandular Autoimmune Syndrome Type I
por: Sardesai, Vidyadhar R, et al.
Publicado: (2013)

Alopecia Universalis Associated with Ulcerative Colitis and The Role of Azathioprine
por: Shohdy, Kyrillus S, et al.
Publicado: (2018)

Improvement in quality of life with sacubitril/valsartan in cardiac resynchronization non-responders: The RESINA (RESynchronization plus an Inhibitor of Neprilysin/Angiotensin) registry
por: Campal, José Manuel Rubio, et al.
Publicado: (2021)

The effects of angiotensin receptor neprilysin inhibition by sacubitril/valsartan on adipose tissue transcriptome and protein expression in obese hypertensive patients
por: Stinkens, R., et al.
Publicado: (2018)

The combination of a neprilysin inhibitor (sacubitril) and angiotensin-II receptor blocker (valsartan) attenuates glomerular and tubular injury in the Zucker Obese rat
por: Habibi, Javad, et al.
Publicado: (2019)

Angiotensin receptor blocker neprilysin inhibitors
por: Usuda, Daisuke, et al.
Publicado: (2021)

Severe Onycholysis in a Card Illusionist with Alopecia Areata Universalis
por: Tosti, Antonella, et al.
Publicado: (2013)

Alopecia universalis during treatment with leflunomide and adalimumab - Case report()
por: Lazzarini, Rosana, et al.
Publicado: (2014)

Treatment of alopecia universalis with oral alitretinoin: A case report
por: Grenier, Pierre-Olivier, et al.
Publicado: (2017)

Effectiveness of Dupilumab in the treatment of both atopic dermatitis and alopecia universalis
por: Call, John E., et al.
Publicado: (2020)

Multiple Autoimmune Syndrome With Alopecia Universalis and Immune Thrombocytopenic Purpura
por: Alwasaidi, Turki A, et al.
Publicado: (2021)

Unexpected hair regrowth in a woman with longstanding Alopecia universalis
por: Akritidou, Fani, et al.
Publicado: (2021)

Prevention against renal damage in rats with subtotal nephrectomy by sacubitril/valsartan (LCZ696), a dual‐acting angiotensin receptor‐neprilysin inhibitor
por: Ushijima, Kentaro, et al.
Publicado: (2017)

Who ‘nose’, is it the angiotensin receptor neprilysin inhibitor?: a case series of persistent nasal pruritus in heart failure patients receiving sacubitril/valsartan
por: Gan, Jaclyn, et al.
Publicado: (2021)

The neprilysin pathway in heart failure: a review and guide on the use of sacubitril/valsartan
por: Jhund, Pardeep S, et al.
Publicado: (2016)

Angiotensin receptor-neprilysin inhibitors and cardiac remodeling
por: Ryazanov, A.S., et al.
Publicado: (2023)

Alopecia Universalis, Renal Stones, and Hyperuricemia: A Familial or an Unfamiliar Association
por: Jana, Kalachand, et al.
Publicado: (2014)

Hirschsprung’s disease associated with alopecia universalis congenita: a case report
por: Malik, Sushma, et al.
Publicado: (2016)

Remission of alopecia universalis in a patient with atopic dermatitis treated with dupilumab
por: Smogorzewski, Jan, et al.
Publicado: (2019)

Dupilumab treatment for atopic dermatitis leading to unexpected treatment for alopecia universalis
por: Alniemi, Dema T., et al.
Publicado: (2019)

Alopecia Universalis in a Case of Rheumatoid Arthritis after Treatment with Etanercept
por: Kandpal, Renu
Publicado: (2019)

Rare Presentation of Alopecia Universalis Congenita and Twenty-nail Dystrophy in Siblings
por: Mitra, Debdeep, et al.
Publicado: (2017)

Hairless Gene Nonsense Mutations in Alopecia Universalis: A Case Report
por: Heidary, Hamed, et al.
Publicado: (2021)

Neprilysin Inhibitor–Angiotensin II Receptor Blocker Combination Therapy (Sacubitril/valsartan) Suppresses Atherosclerotic Plaque Formation and Inhibits Inflammation in Apolipoprotein E- Deficient Mice
por: Zhang, Hui, et al.
Publicado: (2019)

Real-world use patterns of angiotensin receptor-neprilysin inhibitor (sacubitril/valsartan) among patients with heart failure within a large integrated health system
por: Kim, Brendan J, et al.
Publicado: (2022)

Not just thinning: A case of alopecia universalis after mild COVID-19
por: Phong, Celine H., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_12n9p766pcu350us67obi08kq1